These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28624478)

  • 1. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoformulation-based sequential combination cancer therapy.
    Shim G; Kim MG; Kim D; Park JY; Oh YK
    Adv Drug Deliv Rev; 2017 Jun; 115():57-81. PubMed ID: 28412324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
    Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
    Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
    Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
    Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antitumor therapy with targeted dual-nanomedicines.
    Dai W; Wang X; Song G; Liu T; He B; Zhang H; Wang X; Zhang Q
    Adv Drug Deliv Rev; 2017 Jun; 115():23-45. PubMed ID: 28285944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoformulations for combination or cascade anticancer therapy.
    Miao L; Guo S; Lin CM; Liu Q; Huang L
    Adv Drug Deliv Rev; 2017 Jun; 115():3-22. PubMed ID: 28624477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.
    Zhang RX; Wong HL; Xue HY; Eoh JY; Wu XY
    J Control Release; 2016 Oct; 240():489-503. PubMed ID: 27287891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic delivery systems for intravenous administration of nucleic acids.
    Schiffelers RM; de Wolf HK; van Rooy I; Storm G
    Nanomedicine (Lond); 2007 Apr; 2(2):169-81. PubMed ID: 17716119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered nanoparticles for drug delivery in cancer therapy.
    Sun T; Zhang YS; Pang B; Hyun DC; Yang M; Xia Y
    Angew Chem Int Ed Engl; 2014 Nov; 53(46):12320-64. PubMed ID: 25294565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
    Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
    Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid for anticancer drug and nucleic acid delivery.
    Dosio F; Arpicco S; Stella B; Fattal E
    Adv Drug Deliv Rev; 2016 Feb; 97():204-36. PubMed ID: 26592477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent and future advances in anticancer drug delivery: an interview with Khaled Greish.
    Greish K
    Ther Deliv; 2018 May; 9(6):409-412. PubMed ID: 29722635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
    Shen S; Liu M; Li T; Lin S; Mo R
    Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy.
    Qiu C; Wu Y; Shi Q; Guo Q; Zhang J; Meng Y; Wang C; Xia F; Wang J; Xu C
    Int J Biol Sci; 2023; 19(3):789-810. PubMed ID: 36778126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.